Literature DB >> 25122689

Different culture conditions modulate the immunological properties of adipose stem cells.

Mimmi Patrikoski1, Jyrki Sivula2, Heini Huhtala2, Mika Helminen2, Fanny Salo2, Bettina Mannerström2, Susanna Miettinen2.   

Abstract

The potential of human adipose stem cells (ASCs) for regenerative medicine has received recognition owing to their ease of isolation and their multilineage differentiation capacity. Additionally, low immunogenicity and immunosuppressive properties make them a relevant cell source when considering immunomodulation therapies and allogeneic stem cell treatments. In the current study, immunogenicity and immunosuppression of ASCs were determined through mixed lymphocyte reactions. The immunogenic response was analyzed after cell isolation and expansion in fetal bovine serum (FBS), human serum (HS)-supplemented medium, and xeno-free and serum-free (XF/SF) conditions. Additionally, the immunophenotype and the secretion of CXC chemokine ligand 8 (CXCL8), CXCL9, CXCL10, C-C chemokine ligand 2 (CCL2), CCL5, interleukin 2 (IL-2), IL-4, IL-6, IL-10, IL-17A, tumor necrosis factor-α, interferon-γ, transforming growth factor-β1, indoleamine 2,3-deoxygenase, Galectin-1, and Galectin-3 were analyzed. The results showed that ASCs were weakly immunogenic when expanded in any of the three conditions. The significantly strongest suppression was observed with cells expanded in FBS conditions, whereas higher ASC numbers were required to display suppression in HS or XF/SF conditions. In addition, statistically significant differences in protein secretion were observed between direct versus indirect cocultures and between different culture conditions. The characteristic immunophenotype of ASCs was maintained in all conditions. However, in XF/SF conditions, a significantly lower expression of CD54 (intercellular adhesion molecule 1) and a higher expression of CD45 (lymphocyte common antigen) was observed at a low passage number. Although culture conditions have an effect on the immunogenicity, immunosuppression, and protein secretion profile of ASCs, our findings demonstrated that ASCs have low immunogenicity and promising immunosuppressive potential whether cultured in FBS, HS, or XF/SF conditions. ©AlphaMed Press.

Entities:  

Keywords:  Adipose stem cells; Cellular therapy; Cytokines; Immunogenicity; Immunosuppression; Serum-free

Mesh:

Year:  2014        PMID: 25122689      PMCID: PMC4181391          DOI: 10.5966/sctm.2013-0201

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  79 in total

Review 1.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

2.  Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Authors:  Sara M Melief; Jaap Jan Zwaginga; Willem E Fibbe; Helene Roelofs
Journal:  Stem Cells Transl Med       Date:  2013-05-21       Impact factor: 6.940

3.  Adipose-derived stromal cells: Their identity and uses in clinical trials, an update.

Authors:  Louis Casteilla; Valérie Planat-Benard; Patrick Laharrague; Béatrice Cousin
Journal:  World J Stem Cells       Date:  2011-04-26       Impact factor: 5.326

4.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

5.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

6.  Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice.

Authors:  P Niemeyer; J Vohrer; H Schmal; P Kasten; J Fellenberg; N P Suedkamp; A T Mehlhorn
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

7.  Mesenchymal stem cells as cellular immunotherapeutics in allogeneic hematopoietic stem cell transplantation.

Authors:  Claudia Papewalis; Daniela Topolar; Barbara Götz; Stefan Schönberger; Dagmar Dilloo
Journal:  Adv Biochem Eng Biotechnol       Date:  2013       Impact factor: 2.635

8.  Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow.

Authors:  Daniel A De Ugarte; Zeni Alfonso; Patricia A Zuk; Amir Elbarbary; Min Zhu; Peter Ashjian; Prosper Benhaim; Mare H Hedrick; John K Fraser
Journal:  Immunol Lett       Date:  2003-10-31       Impact factor: 3.685

9.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

Review 10.  Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.

Authors:  Nayoun Kim; Keon-Il Im; Jung-Yeon Lim; Eun-Joo Jeon; Young-Sun Nam; Eun-Jung Kim; Seok-Goo Cho
Journal:  Ann Hematol       Date:  2013-05-31       Impact factor: 3.673

View more
  15 in total

1.  Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.

Authors:  Trivia Frazier; Christopher Williams; Michael Henderson; Tamika Duplessis; Emma Rogers; Xiying Wu; Katie Hamel; Elizabeth C Martin; Omair Mohiuddin; Shahensha Shaik; Ram Devireddy; Brian G Rowan; Daniel J Hayes; Jeffrey M Gimble
Journal:  Tissue Eng Part A       Date:  2021-03-10       Impact factor: 3.845

Review 2.  Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease.

Authors:  Joseph P McGuirk; J Robert Smith; Clint L Divine; Micheal Zuniga; Mark L Weiss
Journal:  Pharmaceuticals (Basel)       Date:  2015-04-16

Review 3.  Stem cell technology for tendon regeneration: current status, challenges, and future research directions.

Authors:  Pauline Po Yee Lui
Journal:  Stem Cells Cloning       Date:  2015-12-11

Review 4.  Making the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell Expansion.

Authors:  Carla Dessels; Marnie Potgieter; Michael S Pepper
Journal:  Front Cell Dev Biol       Date:  2016-10-17

Review 5.  Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy.

Authors:  Magdalena M Schimke; Sabrina Marozin; Günter Lepperdinger
Journal:  Front Physiol       Date:  2015-12-02       Impact factor: 4.566

6.  Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.

Authors:  Maria C Naskou; Scarlett M Sumner; Anna Chocallo; Hannah Kemelmakher; Merrilee Thoresen; Ian Copland; Jacques Galipeau; John F Peroni
Journal:  Stem Cell Res Ther       Date:  2018-03-22       Impact factor: 6.832

Review 7.  Perspectives for Clinical Translation of Adipose Stromal/Stem Cells.

Authors:  Mimmi Patrikoski; Bettina Mannerström; Susanna Miettinen
Journal:  Stem Cells Int       Date:  2019-05-02       Impact factor: 5.443

Review 8.  Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application.

Authors:  Simona Ceccarelli; Paola Pontecorvi; Eleni Anastasiadou; Claudio Napoli; Cinzia Marchese
Journal:  Front Cell Dev Biol       Date:  2020-04-17

9.  Three-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia.

Authors:  Yuejiao Li; Yankai Dong; Ye Ran; Yanan Zhang; Boyao Wu; Jundong Xie; Yanpei Cao; Miaohua Mo; Sen Li; Hao Deng; Wenbo Hao; Shengyuan Yu; Yaojiong Wu
Journal:  Stem Cell Res Ther       Date:  2021-06-21       Impact factor: 6.832

Review 10.  Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering.

Authors:  Girdhari Rijal; Weimin Li
Journal:  J Biol Eng       Date:  2018-09-12       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.